Cita APA

Yoneyama, K., Schmitt, C., Kotani, N., Levy, G. G., Kasai, R., Iida, S., . . . Kawanishi, T. (2017). A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A. Clin Pharmacokinet.

Chicago Style Citation

Yoneyama, Koichiro, Christophe Schmitt, Naoki Kotani, Gallia G. Levy, Ryu Kasai, Satofumi Iida, Midori Shima, i Takehiko Kawanishi. "A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A." Clin Pharmacokinet 2017.

Cita MLA

Yoneyama, Koichiro, et al. "A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A." Clin Pharmacokinet 2017.